Utama › Aterosklerosis › Alabama
Kajian klinikal Aterosklerosis di Alabama
8 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Birmingham Clinical Research, Birmingham
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Alliance For Multispecialty Research - Daphne, Daphne
- Eastern Shore Research Institute, Fairhope
- Heart Center Research LLC, Huntsville
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Heart Center Research, LLC, Huntsville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07521007Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Athens
- Research Site, Birmingham
- Research Site, Birmingham
- dan 8 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Parkway Medical Center, Birmingham
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06875973Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 18 hingga 55 · Semua jantina · Dikemas kini 3 Sep 2025 · NCT06962488Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.